Dr. Hormigo on the Impact of COVID-19 on High Density Areas

Video

Adilia Hormigo, MD, PhD, discusses the impact of the coronavirus disease 2019 (COVID-19) on high density areas.

Adilia Hormigo, MD, PhD, director of the neuro-oncology program, professor of neurology, neurosurgery, and medicine, Tisch Cancer Institute, Mount Sinai Hospital, discusses the impact of the coronavirus disease 2019 (COVID-19) on high density areas.

There have been less admissions to the intensive care unit at Mount Sinai and other metropolitan hospitals, suggesting that New York City may be past the peak of COVID-19, says Hormigo.

However, it is hard to determine when the city can safely begin to open. When the city does reopen, it is unlikely to operate as it did prior to the pandemic, says Hormigo. For such dense areas such as New York City, it will be difficult to enforce social distancing.

Related Videos
Catherine C. Coombs, MD, associate clinical professor, medicine, University of California, Irvine School of Medicine
Naomi Adjei, MD, MPH, MSEd, gynecologic oncology fellow, The University of Texas MD Anderson Cancer Center
John M. Kirkwood, MD, Distinguished Service Professor of Medicine, Sandra and Thomas Usher Professor of Medicine, Dermatology & Translational Science, coleader, Melanoma and Skin Cancer Program, Division of Hematology/Oncology, the University of Pittsburgh
Nizar M. Tannir, MD, FACP, professor; Ransom Horne, Jr. Professor for Cancer Research, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
William B. Pearse, MD
Daniel Olson, MD
Nan Chen, MD
Robert Dreicer, MD, director, Solid Tumor Oncology, Division of Hematology/Oncology, professor of Medicine and Urology, deputy director, University of Virginia Cancer Center
Akriti Jain, MD
Samer A. Srour, MB ChB, MS